GAW20: methods and strategies for the new frontiers of epigenetics and pharmacogenomics

GAW20 provided a platform for developing and evaluating statistical methods to analyze human lipid-related phenotypes, DNA methylation, and single-nucleotide markers in a study involving a pharmaceutical intervention. In this article, we present an overview of the data sets and the contributions ana...

Full description

Saved in:
Bibliographic Details
Published in:BMC proceedings 2018-09, Vol.12 (Suppl 9), p.26-26, Article 26
Main Authors: Tintle, Nathan L, Fardo, David W, de Andrade, Mariza, Aslibekyan, Stella, Bailey, Julia N, Bermejo, Justo Lorenzo, Cantor, Rita M, Ghosh, Saurabh, Melton, Philip, Wang, Xuexia, MacCluer, Jean W, Almasy, Laura
Format: Article
Language:English
Subjects:
Proceedings
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:GAW20 provided a platform for developing and evaluating statistical methods to analyze human lipid-related phenotypes, DNA methylation, and single-nucleotide markers in a study involving a pharmaceutical intervention. In this article, we present an overview of the data sets and the contributions analyzing these data. The data, donated by the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) investigators, included data from 188 families (  = 1105) which included genome-wide DNA methylation data before and after a 3-week treatment with fenofibrate, single-nucleotide polymorphisms, metabolic syndrome components before and after treatment, and a variety of covariates. The contributions from individual research groups were extensively discussed prior, during, and after the Workshop in groups based on discussion themes, before being submitted for publication.
ISSN:1753-6561
1753-6561
DOI:10.1186/s12919-018-0113-1